Published in J Bacteriol on April 18, 2008
Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol (2014) 1.40
Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One (2014) 0.95
Minor modifications to the phosphate groups and the C3' acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation. J Biol Chem (2013) 0.92
NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis. Mol Microbiol (2012) 0.90
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect Immun (2013) 0.89
Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity. Infect Immun (2009) 0.87
Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis. J Bacteriol (2011) 0.83
Structural characterization of Bordetella parapertussis lipid A. J Lipid Res (2008) 0.82
Burkholderia cenocepacia and Salmonella enterica ArnT proteins that transfer 4-amino-4-deoxy-l-arabinose to lipopolysaccharide share membrane topology and functional amino acids. Sci Rep (2015) 0.82
Bordetella pertussis lipid A glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation. Antimicrob Agents Chemother (2014) 0.80
Chemical synthesis of Burkholderia Lipid A modified with glycosyl phosphodiester-linked 4-amino-4-deoxy-β-L-arabinose and its immunomodulatory potential. Chemistry (2015) 0.80
Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces. J Biol Chem (2015) 0.78
Elucidation of a novel lipid A α-(1,1)-GalA transferase gene (rgtF) from Mesorhizobium loti: Heterologous expression of rgtF causes Rhizobium etli to synthesize lipid A with α-(1,1)-GalA. Glycobiology (2013) 0.77
Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells. Infect Immun (2014) 0.76
Antimicrobial Peptide Resistance Genes in the Plant Pathogen Dickeya dadantii. Appl Environ Microbiol (2016) 0.75
Structural and biological characteristics of different forms of V. filiformis lipid A: use of MS to highlight structural discrepancies. J Lipid Res (2017) 0.75
Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation. PLoS One (2016) 0.75
ArnT proteins that catalyze the glycosylation of lipopolysaccharide share common features with bacterial N-oligosaccharyltransferases. Glycobiology (2015) 0.75
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Innate immune recognition. Annu Rev Immunol (2001) 26.65
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
Genetic applications of an inverse polymerase chain reaction. Genetics (1988) 18.48
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet (2003) 9.13
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol (2005) 5.25
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Improved techniques for the preparation of bacterial lipopolysaccharides. Can J Microbiol (1976) 4.62
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol (2003) 3.06
An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. J Biol Chem (2001) 2.95
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog (2005) 2.71
Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin. Carbohydr Res (1988) 2.55
Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol (2004) 2.52
Structure and function of lipopolysaccharides. Microbes Infect (2002) 2.49
Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends Microbiol (2000) 2.47
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect Immun (1989) 2.40
A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J Biol Chem (2000) 2.32
Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol (2002) 2.05
Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect (2001) 1.91
Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem (2000) 1.76
Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol (2006) 1.70
A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose. J Biol Chem (2005) 1.66
Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res (2005) 1.53
Microextraction of bacterial lipid A: easy and rapid method for mass spectrometric characterization. J Lipid Res (2005) 1.53
Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol (1990) 1.48
Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida. Biochemistry (2006) 1.47
Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem (1989) 1.42
Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis. FEMS Microbiol Lett (1992) 1.37
Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol (2003) 1.35
A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A. Eur J Biochem (1978) 1.32
Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect (2002) 1.30
Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect Immun (1980) 1.25
Dissemination of lipid A deacylases (pagL) among gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem (2004) 1.22
Complete structures of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides. J Biol Chem (2006) 1.20
Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol (1986) 1.15
The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4. Infect Immun (2002) 1.14
Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett (2000) 1.13
A MurG assay which utilises a synthetic analogue of lipid I. FEMS Microbiol Lett (2003) 1.11
pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun (2004) 1.06
Vag8, a Bordetella pertussis bvg-regulated protein. Infect Immun (1998) 1.06
Novel variation of lipid A structures in strains of different Yersinia species. FEBS Lett (2000) 1.02
Structural variability and originality of the Bordetella endotoxins. J Endotoxin Res (2001) 1.02
Structure of a hexasaccharide proximal to the hydrophobic region of lipopolysaccharides present in Bordetella pertussis endotoxin preparations. Carbohydr Res (1994) 1.00
A rapid, small-scale procedure for the structural characterization of lipid A applied to Citrobacter and Bordetella strains: discovery of a new structural element. J Lipid Res (2007) 0.98
Influence of the supramolecular structure of free lipid A on its biological activity. Eur J Biochem (1993) 0.96
Direct microextraction and analysis of rough-type lipopolysaccharides by combined thin-layer chromatography and MALDI mass spectrometry. Anal Chem (2001) 0.96
The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction. FEMS Immunol Med Microbiol (1994) 0.92
Simple method for repurification of endotoxins for biological use. Appl Environ Microbiol (2007) 0.92
Comparison of lipids A of several Salmonella and Escherichia strains by 252Cf plasma desorption mass spectrometry. J Bacteriol (1993) 0.89
Inability of pyrogenic, purified Bordetella pertussis lipid A to induce interleukin-1 release by human monocytes. Infect Immun (1986) 0.89
Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution. J Bacteriol (1997) 0.89
Specific and cross-reacting monoclonal antibodies to Bordetella parapertussis and Bordetella bronchiseptica lipopolysaccharides. Microbiology (1994) 0.88
Dissociation of cell-associated interleukin-1 (IL-1) and IL-1 release induced by lipopolysaccharide and lipid A. Infect Immun (1989) 0.87
252Cf plasma desorption mass spectrometry applied to the analysis of underivatized rough-type endotoxin preparations. J Biol Chem (1993) 0.87
Structure of the lipid A of Bordetella hinzii ATCC 51730. Rapid Commun Mass Spectrom (2000) 0.86
Interleukin-1 induction by lipopolysaccharides: structural requirements of the 3-deoxy-D-manno-2-octulosonic acid (KDO). Mol Immunol (1989) 0.85
Helicobacter mustelae lipid A structure differs from that of Helicobacter pylori. FEBS Lett (2001) 0.83
Epitopes of Bordetella pertussis lipopolysaccharides as potential markers for typing of isolates with monoclonal antibodies. Microbiology (1996) 0.83
Separation and characterization of O-deacylated lipooligosaccharides and glycans derived from Moraxella catarrhalis using capillary electrophoresis-electrospray mass spectrometry and tandem mass spectrometry. Anal Biochem (1996) 0.83
Structural features involved in the mitogenic activity of Bordetella pertussis lipopolysaccharides for spleen cells of C3H/HeJ mice. FEMS Immunol Med Microbiol (1993) 0.80
Distribution of lipid A species between long and short chain lipopolysaccharides isolated from Salmonella, Yersinia, and Escherichia as seen by 252Cf plasma desorption mass spectrometry. J Biol Chem (1994) 0.80
Lipopolysaccharide of Rhodospirillum salinarum 40: structural studies on the core and lipid A region. Arch Microbiol (1995) 0.79
Chemical and serological characterization of the Bordetella hinzii lipopolysaccharides. FEBS Lett (2000) 0.79
Structural characterization of the O-chain polysaccharide isolated from Bordetella avium ATCC 5086: variation on a theme(1). FEBS Lett (2003) 0.79
Amino sugar analysis by gas-liquid chromatography. J Biochem (1969) 0.78
A nonsubstituted primary hydroxyl group in position 6' of free lipid A is required for binding of lipid A monoclonal antibodies. Infect Immun (1997) 0.78
Structure of the Bordetella trematum LPS O-chain subunit. FEBS Lett (2005) 0.76
Peptidoglycan structure and architecture. FEMS Microbiol Rev (2008) 6.69
Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem (2003) 3.83
The Drosophila amidase PGRP-LB modulates the immune response to bacterial infection. Immunity (2006) 3.51
The Drosophila immune system detects bacteria through specific peptidoglycan recognition. Nat Immunol (2003) 3.29
Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep (2004) 2.64
The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation. J Bacteriol (2008) 2.39
Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev (2008) 2.33
Protein secretion through autotransporter and two-partner pathways. Biochim Biophys Acta (2004) 1.91
Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol (2005) 1.90
The bacA gene of Escherichia coli encodes an undecaprenyl pyrophosphate phosphatase activity. J Biol Chem (2004) 1.71
Microextraction of bacterial lipid A: easy and rapid method for mass spectrometric characterization. J Lipid Res (2005) 1.53
Synthesis of mosaic peptidoglycan cross-bridges by hybrid peptidoglycan assembly pathways in gram-positive bacteria. J Biol Chem (2004) 1.51
Colicin M exerts its bacteriolytic effect via enzymatic degradation of undecaprenyl phosphate-linked peptidoglycan precursors. J Biol Chem (2006) 1.44
The peptidoglycan sacculus of Myxococcus xanthus has unusual structural features and is degraded during glycerol-induced myxospore development. J Bacteriol (2008) 1.40
Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol (2003) 1.35
Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis. J Biol Chem (2004) 1.31
Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium. J Biol Chem (2002) 1.26
Polar localization of the autotransporter family of large bacterial virulence proteins. J Bacteriol (2006) 1.24
Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J Med Chem (2010) 1.15
Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis. Biochemistry (2008) 1.11
A MurG assay which utilises a synthetic analogue of lipid I. FEMS Microbiol Lett (2003) 1.11
Human- and plant-pathogenic Pseudomonas species produce bacteriocins exhibiting colicin M-like hydrolase activity towards peptidoglycan precursors. J Bacteriol (2009) 1.09
Substrate specificity and membrane topology of Escherichia coli PgpB, an undecaprenyl pyrophosphate phosphatase. J Biol Chem (2008) 1.08
Deciphering the catalytic domain of colicin M, a peptidoglycan lipid II-degrading enzyme. J Biol Chem (2010) 1.05
The Au(n) cluster probe in secondary ion mass spectrometry: influence of the projectile size and energy on the desorption/ionization rate from biomolecular solids. Rapid Commun Mass Spectrom (2005) 1.01
Activation of the L,D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D,D-carboxypeptidase in Enterococcus faecium. Mol Microbiol (2009) 0.99
A rapid, small-scale procedure for the structural characterization of lipid A applied to Citrobacter and Bordetella strains: discovery of a new structural element. J Lipid Res (2007) 0.98
Functional and biochemical analysis of the Chlamydia trachomatis ligase MurE. J Bacteriol (2009) 0.98
The MurE synthetase from Thermotoga maritima is endowed with an unusual D-lysine adding activity. J Biol Chem (2006) 0.97
Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity. J Bacteriol (2003) 0.97
Association of hemolytic activity of Pseudomonas entomophila, a versatile soil bacterium, with cyclic lipopeptide production. Appl Environ Microbiol (2009) 0.96
Biochemical characterisation of the chlamydial MurF ligase, and possible sequence of the chlamydial peptidoglycan pentapeptide stem. Arch Microbiol (2012) 0.96
Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase. J Mol Biol (2007) 0.95
Minor modifications to the phosphate groups and the C3' acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation. J Biol Chem (2013) 0.92
Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach. Bioorg Med Chem Lett (2009) 0.92
Fluorescence detection-based functional assay for high-throughput screening for MraY. Antimicrob Agents Chemother (2004) 0.92
Biochemical characterization and physiological properties of Escherichia coli UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl-meso-diaminopimelate ligase. J Bacteriol (2007) 0.92
Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme. J Med Chem (2008) 0.92
Simple method for repurification of endotoxins for biological use. Appl Environ Microbiol (2007) 0.92
5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases. ChemMedChem (2010) 0.91
Biochemical disclosure of the mycolate outer membrane of Corynebacterium glutamicum. J Bacteriol (2011) 0.89
Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes. Innate Immun (2009) 0.89
MurC and MurD synthetases of peptidoglycan biosynthesis: borohydride trapping of acyl-phosphate intermediates. Methods Enzymol (2002) 0.89
Functional and structural characterization of PaeM, a colicin M-like bacteriocin produced by Pseudomonas aeruginosa. J Biol Chem (2012) 0.89
Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob Agents Chemother (2005) 0.89
Phosphinate Inhibitors of the D-Glutamic Acid-Adding Enzyme of Peptidoglycan Biosynthesis. J Org Chem (1996) 0.89
Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. Bioorg Chem (2009) 0.88
Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains. J Infect Dis (2010) 0.88
Quantitative high-performance liquid chromatography analysis of the pool levels of undecaprenyl phosphate and its derivatives in bacterial membranes. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.88
The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance. Mol Microbiol (2013) 0.88
Matrix-implanted laser desorption/ionization mass spectrometry. Anal Chem (2004) 0.88
Purification and biochemical characterization of Mur ligases from Staphylococcus aureus. Biochimie (2010) 0.87
A detailed study of the amino acids produced from the vacuum UV irradiation of interstellar ice analogs. Orig Life Evol Biosph (2008) 0.86
X-ray structure and site-directed mutagenesis analysis of the Escherichia coli colicin M immunity protein. J Bacteriol (2010) 0.85
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening. Bioorg Med Chem (2009) 0.85
Colicin M hydrolyses branched lipids II from Gram-positive bacteria. Biochimie (2011) 0.84
New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation. Eur J Med Chem (2011) 0.84
Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD. Bioorg Med Chem Lett (2005) 0.84
Role of the amino acid invariants in the active site of MurG as evaluated by site-directed mutagenesis. Biochimie (2007) 0.84
Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of D-glutamic acid. Eur J Med Chem (2011) 0.83
Structure-based design of a new series of D-glutamic acid based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD). J Med Chem (2011) 0.83
Glycosyl transferase activity of the Escherichia coli penicillin-binding protein 1b: specificity profile for the substrate. Biochemistry (2006) 0.83
Structural characterization of Bordetella parapertussis lipid A. J Lipid Res (2008) 0.82
Preparative enzymatic synthesis of polyprenyl-pyrophosphoryl-N-acetylglucosamine, an essential lipid intermediate for the biosynthesis of various bacterial cell envelope polymers. Anal Biochem (2009) 0.82
Structural modifications occurring in lipid A of Bordetella bronchiseptica clinical isolates as demonstrated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2011) 0.82
The structure of FemX(Wv) in complex with a peptidyl-RNA conjugate: mechanism of aminoacyl transfer from Ala-tRNA(Ala) to peptidoglycan precursors. Angew Chem Int Ed Engl (2013) 0.82
Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity. Innate Immun (2013) 0.82
Colicin M, a peptidoglycan lipid-II-degrading enzyme: potential use for antibacterial means? Biochem Soc Trans (2012) 0.82
Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase (MurE). Arch Pharm (Weinheim) (2007) 0.82
Biochemical characterization of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate ligase (MurE) from Verrucomicrobium spinosum DSM 4136(T.). PLoS One (2013) 0.81
Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF. Eur J Med Chem (2013) 0.80
Virtual screening for potential inhibitors of bacterial MurC and MurD ligases. J Mol Model (2011) 0.80
Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase. Bioorg Med Chem Lett (2008) 0.80
MurD enzymes from different bacteria: evaluation of inhibitors. Biochem Pharmacol (2012) 0.79
Structural characterization of the O-chain polysaccharide isolated from Bordetella avium ATCC 5086: variation on a theme(1). FEBS Lett (2003) 0.79
The GTPase CpgA is implicated in the deposition of the peptidoglycan sacculus in Bacillus subtilis. J Bacteriol (2008) 0.79
Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting D-Glu- and diphosphate-binding sites. Eur J Med Chem (2011) 0.79
Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents. Molecules (2008) 0.79
Characterization of colicin M and its orthologs targeting bacterial cell wall peptidoglycan biosynthesis. Microb Drug Resist (2012) 0.79
MurD enzymes: some recent developments. Biomol Concepts (2013) 0.78
The elucidation of the structure of Thermotoga maritima peptidoglycan reveals two novel types of cross-link. J Biol Chem (2009) 0.78
Efficient access to peptidyl-RNA conjugates for picomolar inhibition of non-ribosomal FemX(Wv) aminoacyl transferase. Chemistry (2012) 0.77
A new rapid and micro-scale hydrolysis, using triethylamine citrate, for lipopolysaccharide characterization by mass spectrometry. Rapid Commun Mass Spectrom (2011) 0.77
Two-dimensional DNA displays for comparisons of bacterial genomes. Biol Proced Online (2003) 0.77
Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases. ChemMedChem (2008) 0.76
Design, Synthesis and in vitro Biochemical Activity of Novel Amino Acid Sulfonohydrazide Inhibitors of MurC. Acta Chim Slov (2011) 0.76
Specificity determinants for lysine incorporation in Staphylococcus aureus peptidoglycan as revealed by the structure of a MurE enzyme ternary complex. J Biol Chem (2013) 0.76
The binding mode of second-generation sulfonamide inhibitors of MurD: clues for rational design of potent MurD inhibitors. PLoS One (2012) 0.76
Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm). Eur J Med Chem (2013) 0.76
Structure of the Bordetella trematum LPS O-chain subunit. FEBS Lett (2005) 0.76
Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era. Carbohydr Res (2013) 0.75
Design and Synthesis of New Peptidomimetics as Potential Inhibitors of MurE. Acta Chim Slov (2011) 0.75
Biochemical characterization of MurF from Streptococcus pneumoniae and the identification of a new MurF inhibitor through ligand-based virtual screening. Acta Chim Slov (2013) 0.75
Synthetic tripeptides as alternate substrates of murein peptide ligase (Mpl). Biochimie (2012) 0.75
Purification and biochemical characterisation of GlmU from Yersinia pestis. Arch Microbiol (2014) 0.75
Crystallization and preliminary X-ray analysis of Weissella viridescens FemX UDP-MurNAc-pentapeptide:l-alanine ligase. Acta Crystallogr D Biol Crystallogr (2003) 0.75
Enantioselective synthesis of α-benzylated lanthionines and related tripeptides for biological incorporation into E. coli peptidoglycan. Org Biomol Chem (2014) 0.75